Par Formulations Pvt Ltd agreed to acquire Pharmaceutical Business from Wintac Limited (BSE:524758) for $15.3 million on April 26, 2018. The transaction is subject to the approval by the shareholders of Wintac Limited and receipt of regulatory approvals. Board of Directors of Wintac Limited approved the transaction on April 26, 2018. The transaction is expected to complete before end of 2018.